OTCMKTS:SCRCQ

ScripsAmerica Stock Forecast, Price & News

$0.0039
0.00 (0.00 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
▼
$0.01
VolumeN/A
Average Volume562,837 shs
Market Capitalization$532,779.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.81
30 days | 90 days | 365 days | Advanced Chart
Receive SCRCQ News and Ratings via Email

Sign-up to receive the latest news and ratings for ScripsAmerica and its competitors with MarketBeat's FREE daily newsletter.


ScripsAmerica logo

About ScripsAmerica

ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Clifton, New Jersey. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2016.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Medical Sector

2090th out of 2,105 stocks

Drugs, Proprietaries, & Sundries Industry

13th out of 14 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











ScripsAmerica (OTCMKTS:SCRCQ) Frequently Asked Questions

What stocks does MarketBeat like better than ScripsAmerica?

Wall Street analysts have given ScripsAmerica a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ScripsAmerica wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are ScripsAmerica's key executives?

ScripsAmerica's management team includes the following people:
  • Mr. Brian Ettinger, Chairman & CEO (Age 68, Pay $6k)
  • Mr. Jeffrey J. Andrews CPA, Chief Financial Officer (Age 69)

Who are some of ScripsAmerica's key competitors?

Some companies that are related to ScripsAmerica include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), (BTCA) (BTCA), PetIQ (PETQ), Trxade Group (TRXD), TRxADE HEALTH (MEDS), Bioasis Technologies (BIOAF), Medizone International (MZEIQ), China Medicine (CHME) and China BCT Pharmacy Group (CNBI).
View all of SCRCQ's competitors.

What is ScripsAmerica's stock symbol?

ScripsAmerica trades on the OTCMKTS under the ticker symbol "SCRCQ."

How do I buy shares of ScripsAmerica?

Shares of SCRCQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ScripsAmerica's stock price today?

One share of SCRCQ stock can currently be purchased for approximately $0.00.

How much money does ScripsAmerica make?

ScripsAmerica has a market capitalization of $532,779.00.

How many employees does ScripsAmerica have?

ScripsAmerica employs 21 workers across the globe.

What is ScripsAmerica's official website?

The official website for ScripsAmerica is www.scripsamerica.com.

Where are ScripsAmerica's headquarters?

ScripsAmerica is headquartered at 1094 MAIN AVENUE SUITE A, CLIFTON NJ, 07011.

How can I contact ScripsAmerica?

ScripsAmerica's mailing address is 1094 MAIN AVENUE SUITE A, CLIFTON NJ, 07011. The company can be reached via phone at 800-957-7622.


This page was last updated on 6/22/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.